Enallylpropymal (Narconumal) is a barbiturate derivative developed by Hoffman la Roche in the 1930s.[1] It has sedative and hypnotic effects and is considered to have a moderate abuse potential.[2]
Clinical data | |
---|---|
Other names | Enallylpropymal |
ATC code |
|
Identifiers | |
| |
CAS Number |
|
PubChem CID |
|
ChemSpider |
|
UNII |
|
ECHA InfoCard | 100.015.876 |
Chemical and physical data | |
Formula | C11H16N2O3 |
Molar mass | 224.260 g·mol−1 |
3D model (JSmol) |
|
Chirality | Racemic mixture |
| |
| |
(verify) |